Industry Developments

The next step up in Chinese healthcare diplomacy in Africa will be the acceleration of pharmaceutical and medical device exports, joint ventures in private healthcare provision and,... 2011-11-23

BMI View: The proposal of new taxation structures to facilitate a national healthcare system in Lebanon presents upside risks for healthcare expenditure. However, with a possible review... 2011-11-23

BMI View: As the Gulf Cooperation Council (GCC) is pushing the financial burden of healthcare on to individuals, through the mandating of compulsory health insurance, regulations will... 2011-11-21

BMI View: While emerging pharmaceutical markets are a fantastic growth story, the use of higher prices for drugs in emerging markets to offset the austerity of Europe and US healthcare... 2011-11-18

BMI View: While not an easily commercialised event, the hajj pilgrimage to Mecca is an enormous healthcare challenge requiring huge volumes of vaccines, over-the-counter (OTC) drugs... 2011-11-17

BMI View: While Zambian President Michael Sata's fervour to increase public expenditure on healthcare presents opportunities for generic drugmakers and medical device manufacturers,... 2011-11-16

BMI View: Although there is both the demand and the macroeconomic growth to support the entry of innovative multinational drugmakers into Africa, there seems to be little incentive... 2011-11-15

BMI View: The Global Fund's financial shortfall is incredibly disappointing for Africa, but unsurprising given the global sovereign debt crisis that is seeing aid budgets being squeezed... 2011-11-11

BMI View: Our view that industrial action in Israel would result in an increase in public healthcare expenditure has played out. The government is promising an additional ILS2.7bn (US$764mn)... 2011-11-10

BMI View: While the biotechnology parks of Dubai and Saudi Arabia have attracted some big names in the global industry, we are concerned that they may have become glorified tax havens... 2011-11-09